Publications
Now that the patent has expired, this cancer drug is suddenly 99% cheaper
March 24, 2022
The patent on the cancer drug Revlimid (lenalidomide) recently expired. Whereas a few weeks ago a pack still cost over 4,500 euros, after generic comp
